суббота, 29 октября 2016 г.

Quidel Corp. (QDEL) Rating Lowered to Sell at Zacks Investment Research

Quidel Corp. (QDEL) Rating Lowered to Sell at Zacks Investment Research


According to Zacks, "Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis.



from Biotech News